Placebo and Active Comparator Controlled Dose Response Study of Rivoglitazone in Type 2 Diabetes (RAISE)

This study has been completed.
Information provided by:
Daiichi Sankyo Inc. Identifier:
First received: December 14, 2007
Last updated: February 6, 2009
Last verified: February 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2009
  Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)